Search results
Aaron Rodgers Sparks Outrage After Outlandish Claims About U.S. Government, Dr. Anthony Fauci...
Men's Journal via Yahoo News· 1 day agoNew York Jets star Aaron Rodgers has seemingly made as many headlines for his words off the field as...
How Moderna’s CIO helps steer the drugmaker’s post-COVID evolution
Fortune via AOL· 1 day agoBrad Miller is helping Moderna shift from its reliance on COVID vaccines, with the company hoping to...
Aaron Rodgers thinks the government engineered HIV, and 9 other unhinged things he's said
Pride via Yahoo News· 12 hours agoHowever, reality has never seemed to deter Rodgers from speaking, as he spews a disproven conspiracy...
Moderna, Inc. (NASDAQ:MRNA) President Stephen Hoge Sells 15,000 Shares
ETF DAILY NEWS· 22 hours agoModerna, Inc. (NASDAQ:MRNA – Get Free Report) President Stephen Hoge sold 15,000 shares of Moderna stock in a transaction dated Monday, April 15th. Following ...
Moderna (MRNA) Stock Moves -0.34%: What You Should Know
Zacks via Yahoo Finance· 1 day agoIn the latest trading session, Moderna (MRNA) closed at $103.44, marking a -0.34% move from the...
RFK Jr.’s Running Mate Sets New Low for Anti-Vax Misinformation
The Daily Beast via Yahoo News· 2 days ago“It is not a safe vaccine, and must be recalled immediately. Many people are suffering who took it,”...
Moderna director Noubar Afeyan sells over $1.6m in company stock By Investing.com
Investing.com· 6 days agoIn a recent transaction, Noubar Afeyan, a director at Moderna , Inc. (NASDAQ:MRNA), sold a...
Who can get a Covid booster this spring and how can you book?
BBC via Yahoo News· 5 days agoSpring vaccinations will be available until 30 June. Which vaccine will people get? Vaccines from...
Moderna, Inc. (MRNA) is Attracting Investor Attention: Here is What You Should Know
Zacks· 3 days agoFree Report) has been one of the most searched-for stocks on Zacks.com lately. Over the past month, shares of this biotechnology company have returned -0.4%, compared to the Zacks S&P 500 composite's ...
Moderna (NASDAQ:MRNA) Receives Hold Rating from Needham & Company LLC
ETF DAILY NEWS· 7 days agoNeedham & Company LLC restated their hold rating on shares of Moderna (NASDAQ:MRNA – Free Report) in a research note released on Thursday, Benzinga reports. Several other ...